Nabriva Therapeutics is a biopharmaceutical company that develops and markets anti-infective agents to treat serious infections. The company's products include SIVEXTRO and XENLETA which are used to treat skin and lung infections. The company is also developing XENLETA and CONTEPO for use in treating other infections and is headquartered in Dublin, Ireland.